SCHEMBL6538359

SCHEMBL6538359

Cc1cnc2c(N)ccc(C)c2c1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.39
AXL P30530 1/20 0.36
PRKCI P41743 1/20 0.36
CCR1 P32246 1/20 0.35
CCR5 P51681 1/20 0.35
CCR8 P51685 1/20 0.35
KDM4E B2RXH2 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPT P10636 2/20 0.33
ALDH1A1 P00352 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CASP1 P29466 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
NPC1 O15118 1/20 0.33
ATM Q13315 1/20 0.33
NOS3 P29474 3/20 0.32
NOS2 P35228 3/20 0.32
NOS1 P29475 2/20 0.32
UHRF1 Q96T88 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6538129 0.87 AXL (0.35) CYP3A4AXLPRKCICCR1CCR5
SCHEMBL6537704 0.78 LMNA (0.42) CYP3A4KDM4ELMNA
SCHEMBL6537500 0.74 NR4A2 (0.41) CYP3A4CCR1CCR5CCR8KDM4E
SCHEMBL6538159 0.73 TDP1 (0.46) CYP3A4AXLPRKCICCR1CCR5
SCHEMBL6537327 0.73 MEN1 (0.45) CYP3A4KDM4EMEN1KMT2AMAPT
SCHEMBL436692 0.68 POLB (0.38) CYP3A4CCR1CCR5CCR8KDM4E
SCHEMBL7696376 0.66 NR4A2 (0.40) CYP3A4KDM4EKMT2AALDH1A1TDP1
SCHEMBL30667298 0.65 ELANE (0.44) AXLPRKCIALDH1A1
SCHEMBL3884369 0.65 CYP3A4 (0.50) CYP3A4MEN1KMT2AMAPTALDH1A1
SCHEMBL4657946 0.65 CYP3A4 (0.46) CYP3A4KDM4EMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed